This confirms previously reported observations of differential inhibition of EGFR and MAPK phosphorylation in glioma cell lines (Li et al, 2003) and shows the effectiveness of gefitinib against EGFR signaling in human keratinocytes. The gene discussed is EGFR; the disease is glioma.